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2Summary
We report the characterization of a nucleolar localization sequence (NoLS) that targets the
green fluorescent protein (GFP) into the granular component (GC) of nucleoli. This NoLS
interacts in vitro specifically and directly with the major nucleolar protein B23 and more
precisely with the region of B23 including the two acidic stretches. The affinity of NoLS for
B23 is stronger than that of the HIV-1 Rev protein in vitro. Moreover, B23-NoLS interaction
occurs also in vivo. Indeed, 1) NoLS confers on the GFP the behavior of B23 throughout the
cell cycle, 2) the GFP-NoLS fusion and B23 remain colocalized after drug treatments, 3) a
selective delocalization of B23 from nucleoli to nucleoplasm induces a concomitent
delocalization of the GFP-NoLS fusion, and 4) the fusion of NoLS to fibrillarin makes it
possible to colocalize fibrillarin and B23. Interestingly, by fusing NoLS to fibrillarin, both
fibrillarin and the fibrillarin partner Nop56 are mislocalized in the GC of nucleoli. Similarly
by fusing the NoLS to MafG, part of the nuclear transcription factor NF-E2 composed of both
MafG and p45 NF-E2, NF-E2 is re-directed from the nucleoplasm to the nucleoli. Thus, we
propose that NoLS may be used as a tool to visualize and prove protein interactions in a
cellular context.
3 Introduction
The architecture of the nucleus is complex and the nuclear functions are precisely located in
the nuclear volume. Morphologically distinct structures or nuclear bodies are present. They
correspond to specialized domains implicated in essential processes such as transcription and
splicing (Matera, 1999; Spector, 2001; Strouboulis and Wolffe, 1996), or represent in the case
of the nucleolus the site of ribosome biogenesis (Mélèse and Xue, 1995). This complicated
architecture was proposed to be linked to the dynamics of proteins and RNP complexes in the
nucleus (Misteli, 2001; Phair and Misteli, 2000). In the nucleoplasm, the high mobility of
proteins would ensure their diffusion and availability throughout the nucleus. In nuclear
bodies the mobility of proteins is reduced most probably by interactions with partners. This
determines a residence time based on affinities and functions of the proteins (Chen and
Huang, 2001; Dundr et al., 2004; Snaar et al., 2000). If this model based on analyses of the
nuclear traffic in living cells is correct, protein interactions should govern their nuclear
distribution. By modifying the normal affinity of proteins it might be possible to create
experimental interactions that would provide information and permit analysis of the model.
The nucleolus is the paradigm of functional compartmentation in the nucleus
(Strouboulis and Wolffe, 1996). Ribosomal RNAs (rRNAs) are synthesized, processed and
assembled with ribosomal proteins to form the small 40S and large 60S pre-ribosome subunits
in the nucleolus (for a review, see Fatica and Tollervey, 2002; Gébrane-Younès et al., 2005;
Hernandez-Verdun, 2006; Shaw and Jordan, 1995). The dynamic integration of these
processes generates a typical nucleolar organization revealing the compartmentation of the
different steps. Three main specific components are observed by electron microscopy (Scheer
and Hock, 1999), the fibrillar centers (FCs), the dense fibrillar component (DFC), and the
granular component (GC). In the active nucleolus, the early rRNA processing proteins are
4associated with transcripts during elongation and localized in the internal part of the
nucleolus, i.e. in the DFC. The processing proteins associated with late steps of rRNA
processing are localized in the external region of the nucleolus, i.e. in the GC.
Protein B23 (NPM, nucleophosmin, numatrin or NO38) is an abundant
phosphoprotein localized mainly in the nucleoli during interphase, at the chromosome
periphery during mitosis, and in foci called prenucleolar bodies (PNBs) at the exit from
mitosis. It is a multifunctional protein that has nucleic acid binding, ribonuclease and
molecular chaperone activities. By mapping the functional domains of B23, it was found that
the N-terminal domain of B23 is necessary and sufficient to bind nucleic acids, the molecular
chaperone activity is contained in the N-terminal half of the protein, and the central region of
the molecule is required for ribonuclease activity (Hingorani et al., 2000; Szebeni et al.,
2003). The C-terminal region of B23 is preferentially associated with 28S pre-rRNA and its
ribonuclease activity processes the internal transcribed spacer 2 of the pre-rRNA (Huang et
al., 2005; Itahana et al., 2003; Savkur and Olson, 1998). The chaperone activity of B23 is
controlled by protein kinase CK2 and is most probably linked to the ability of B23 to form
large oligomers in native conditions (Herrera et al., 1996; Szebeni et al., 2003). In addition,
B23 interacts with other nucleolar proteins such as nucleolin (Li et al., 1996), protein p120
(Valdez et al., 1994), ARF (Korgaonkar et al., 2005) and the HIV-1 Rev protein (Fankhauser
et al., 1991). In this latter case B23 could serve as molecular chaperone for Rev (Olson,
2004). In addition, it was also proposed that B23 could play a role in nucleocytoplasmic
transport since it can shuttle between nucleus and cytoplasm (Borer et al., 1989; Fankhauser
et al., 1991). B23 is phosphorylated before mitosis and this modification reduces RNA
binding by B23 (Okuwaki et al., 2002). This suggests that phosphorylation at the beginning of
mitosis may promote B23 translocation from nucleoli to chromosome periphery. Interestingly,
mutated B23 genes were found in a number of cancers and their implication in haematological
5disorders was demonstrated (Grisendi et al., 2005). B23 therefore appears to be a key protein
in ribosome biogenesis and cell cycle.
In the case of nucleolar targeting of viral proteins, it was proposed that a nucleolar
sequence signal (NoLS) could be involved (Dang and Lee, 1989; Kubota et al., 1989; Siomi et
al., 1988). This is not a particularity of viral proteins since similar sequences were also found
in several endogenous nucleolar proteins (Dang and Lee, 1989; Korgaonkar et al., 2005; Song
and Wu, 2005; Valdez et al., 1994; Weber et al., 2000). In the present study, we have
characterized a novel protein sequence that targets the green fluorescent protein (GFP) to the
GC of nucleoli. This sequence designated NoLS interacts both in vitro and in vivo with B23.
In addition, we show that on one hand, by fusing the NoLS to fibrillarin, both fibrillarin and
Nop56, another member of the core proteins of the box C/D snoRNP complexes, are
relocalized from the DFC to the GC of nucleoli. On the other hand, by fusing the NoLS to
MafG, a subunit of the transcription factor NF-E2 composed of MafG and p45 NF-E2
(Tramier et al., 2002), NF-E2 is re-directed from the nucleoplasm to the GC of the nucleoli.
Thus, we demonstrate here the capability to relocalize nuclear complexes by adding an
affinity for B23 to one subunit of the complex and therefore, we propose that such a B23-
interacting sequence may be used as tool to visualize and to prove protein interactions in a
cellular context by fluorescence microscope observations.
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A novel nucleolar localization sequence
During PCR-amplication of the DNA sequence encoding human Sirtuin 1, a mutant was
generated which showed a nucleolar localization when expressed fused to GFP in HeLa cells.
The analysis of the DNA sequence of this mutant revealed a misreading of the DNA
polymerase having led to the loss of four nucleotides (nt 262-265) of the Sirtuin 1-coding
DNA sequence and consequently, to a change in reading frame (Fig. 1A). Therefore, the
resulting mutant protein corresponds to the first 87 amino acids of Sirtuin 1 followed by a
“synthetic” sequence of 93 amino acids corresponding to the Sirtuin 1 DNA sequence (nt 266-
544). By subcloning both parts of this mutant protein separately into a GFP-fusion plasmid,
we observed that the first 87 amino acids of Sirtuin 1 (∆ Sirtuin 1) expressed fused to the GFP
in HeLa cells did not show any obvious nucleolar localization contrary to the “synthetic”
sequence which was able to address the GFP to the nucleolus. The new sequence (Fig. 1A,B)
was therefore designated NoLS. This novel NoLS possesses no significant homology with the
NoLSs previously described except for the presence of a stretch of basic residues (Fig. 1B, in
red) as already reported for other nucleolus-localizing proteins.
To delineate this NoLS, different constructs were generated (Fig. 1C) and expressed in
HeLa cells as GFP fused proteins (Fig. 1D). Undoubtedly, the stretch of basic residues (in red
Fig. 1B,C) is strongly implicated in nucleolar localization. Indeed, only the constructs NoLS,
NoLS/33-93, NoLS/31-63 and NoLS/1-50 which possessed the stretch of basic residues were
localized mostly if not exclusively in nucleoli, whereas the other constructs were not
(NoLS/51-93) or only slightly (NoLS/1-32) enriched in nucleoli (Fig. 1D). However, the
entire sequence of NoLS seems to be implicated in nucleolar localization. On one hand, the
construct NoLS/1-32 was also slightly enriched in nucleoli and on the other hand, even if the
7construct NoLS/51-93 did not exhibit nucleolar localization (Fig. 1Dk), the C-terminal region
of NoLS appeared to facilitate targeting of the GFP to the nucleolus as observed by
comparing the localization of NoLS/33-93 to that of NoLS/31-63 (Fig. 1Dc and Di). Both
constructs were localized in nucleoli but in the absence of the C-terminal end of NoLS
(Fig. 1Di), a certain level of nucleoplasmic labeling was also observed contrary to what
occurred in the presence of the C-terminal end (Fig. 1Dc). For these reasons, the complete
NoLS was used for all subsequent experiments.
The novel NoLS interacts specifically and directly with B23 in vitro
To further understand how GFP-NoLS localized specifically in nucleoli and since previous
studies had shown that several NoLSs interact with the major nucleolar protein B23 in vitro,
we examined by glutathione S-tranferase (GST) pull down experiments the interaction
between B23 and the novel NoLS (Fig. 2A). For this purpose, a GST-NoLS fusion was
generated and pull down assays were carried out on whole cell extracts. As shown in Fig. 2A,
analysis by Western blot of the bound proteins revealed that B23 interacts with the NoLS
contrary to other nucleolar proteins such as Nopp140, nucleolin the other major nucleolar
protein, and Nop52. The interaction between B23 and the NoLS is direct as demonstrated by
GST-NoLS pull down assays carried out on purified B23 (Fig. 2B). To determine the region
within B23 required for B23-NoLS interaction, various B23 truncation mutants were
generated (Fig. 2C) and expressed in HeLa cells as GFP or DsRed fused proteins. GST-NoLS
pull down were then performed to identify which B23 mutants interacted with NoLS. The
results showed that the central region, i.e. the region including the two acidic stretches of B23
(amino acids 120 to 132 and 161 to 188), governs interaction between B23 and NoLS whereas
neither the N-terminal (amino acids 1 to 119) nor the C-terminal (amino acids 187-294)
region participates in this interaction. In addition, a comparison between the results obtained
8with the mutants B23/1-119, B23/1-132, B23/1-160 and B23/1-186, i.e. the B23 mutants
possessing the B23 residues 1-119, 1-132, 1-160 and 1-186, respectively, indicates that the
first acidic stretch of B23 (amino acids 120 to 132) is sufficient to promote B23-NoLS
interaction.
The novel NoLS has a stronger affinity for B23 than for HIV-1 Rev in vitro
To evaluate the strength of the B23-NoLS interaction, we compared NoLS to the HIV-1 Rev
protein, previously identified as a B23-interacting protein localized in the nucleolus. For this
purpose, the same amounts of GST, GST-NoLS and GST-Rev were bound to sepharose beads
and incubated for increasing times with the same whole HeLa cell extracts. After the GST
pull down assays, the bound proteins were resuspended in SDS-PAGE sample buffer,
electrophoresed and analyzed by coomassie blue staining to check that no significant loss of
GST, GST-NoLS and/or GST-Rev had occurred during the experiments. In parallel, the
sames samples were electrophoresed, Western-blotted onto nitrocellulose membranes and
B23 was detected and quantified. As illustrated for a representative experiment (Fig. 3A,B),
B23 interacts with both NoLS and Rev but the B23-NoLS interaction occurred more rapidly
and the amount of bound B23 was higher than in the B23-Rev interaction. Indeed, the
comparison of the amounts of B23 bound to NoLS and to Rev (Fig. 3B) reveals that the
amount of B23 bound to NoLS was 4 times greater than that bound to Rev after 1.5 hours, 3
times after 3 hours and 2.5 times after 20 hours of incubation. The fact that the NoLS exhibits
a strong affinity for B23 in vitro prompted us to verify the B23-NoLS interaction in vivo.
The novel NoLS interacts specifically with protein B23 in vivo
To precisely locate NoLS in nucleoli and to determine whether this localization is compatible
with B23-NoLS interaction in vivo, we localized the GFP-NoLS fusion together with
9endogenous fibrillarin and B23 in interphasic HeLa cells. As shown Fig. 4A, fibrillarin known
to be localized in the DFC of nucleoli did not colocalize with GFP-NoLS. Conversely B23,
mostly located in the GC of nucleoli, appeared to strictly colocalize with GFP-NoLS
indicating that GFP-NoLS is mostly localized in the GC of nucleoli. In addition, this
colocalization is in agreement with the fact that interaction between B23 and NoLS occurs in
vivo. Concerning mitosis, the behavior of GFP-NoLS appeared to be similar to that of B23
(Fig. 4B). Indeed, as is well known for B23, GFP-NoLS was enriched at the periphery of
chromosomes during metaphase (Fig. 4Ba-d) and recruited in PNBs at telophase (Fig. 4Be-h)
before being relocated in new nucleoli formed in early G1 (Fig. 4Bi-l). Therefore the NoLS
confers on GFP a localization similar to that of B23 throughout the cell cycle.
The localization of NoLS during the cell cycle is compatible with B23-NoLS
interaction in vivo. This is reinforced by the fact that the colocalization of both NoLS and B23
was maintained when HeLa cells were treated with drugs inducing a dramatic reorganization
of the nucleolus (Fig. 5A) and hence relocalization of nucleolar proteins. Indeed after
actinomycin D treatment that inhibits rDNA transcription and consequently induces nucleolar
reorganization (Hadjiolov, 1985), NoLS is colocalized with B23 (Fig. 5Aa-d) and excluded
from caps where fibrillarin is located (Fig. 5Ae-h). Similarly, after treatment with the
cyclin-dependent kinase (CDK) inhibitor roscovitine that also induces dramatic
disorganization of the nucleolus (Sirri et al., 2002), NoLS is still observed colocalized with
B23 (Fig. 5Ai-l) but not with fibrillarin (Fig. 5Am-p).
To prove B23-NoLS interaction in vivo, a human B23 mutant, designated mutant A by
Falini and coworkers (Falini et al., 2005) was used to selectively exclude B23 from the
nucleolus and to follow the localization of NoLS. This B23 mutant corresponds to a
substitution of 11 novel amino acids for the seven C-terminal residues of the wild type B23
generating a consensus nuclear export signal (NES). This B23-NES mutant localizes in the
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cytoplasm of interphasic NIH-3T3 cells when expressed fused to GFP in a Crm1-dependent
manner (Falini et al., 2006). As previously reported (Falini et al., 2006), in the presence of the
Crm1-inhibitor leptomycin B, B23-NES relocates in the nucleus and is mostly excluded from
the nucleoli (Fig. 5Ba,d). Interestingly, most probably due to the capability of B23 to
multimerize, after leptomycin B treatment the endogenous B23 is delocated from nucleoli in
NIH-3T3 cells that express B23-NES, whereas the endogenous B23 remains localized in
nucleoli in cells which do not express B23-NES after the same treatment (Fig. 5Ba-c).
Similarly in NIH-3T3 cells expressing B23-NES and treated with leptomycin B, most of
NoLS leaves the nucleoli and localizes in the nucleoplasm (Fig. 5Bd-f). Since the selective
delocalization of the endogenous B23 from nucleoli to nucleoplasm similarly modifies the
localization of NoLS, we conclude that B23-NoLS interaction occurs in vivo. Consequently,
we propose that fusing the NoLS to GFP confers on GFP a high affinity for B23. This affinity
is maintained throughout the cell cycle, and therefore the GFP-NoLS fusion is able to interact
specifically with B23 in vivo and to adopt the behavior of B23 during interphase as well as
during mitosis.
The novel NoLS may be used as a new tool to visualize protein interactions in
the cell nucleolus
When fused to GFP, the novel NoLS is able to target GFP to the nucleolus by conferring on
the GFP a high affinity for the nucleolar protein B23. However, it may be assumed that GFP
does not possess any particular affinity in eukaryotic cells and therefore that modifying its
localization is easier than for physiological proteins. Consequently, it may be asked whether
addition of the NoLS to a physiological nucleolar protein could modify the localization of this
protein. To answer this question, we localized both fibrillarin-GFP fusion and fibrillarin-
NoLS-GFP fusion together with B23 (expressed as DsRed-B23 fusion) in interphasic HeLa
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cells. As shown Fig. 6a-d, fibrillarin known to be localized in the DFC of nucleoli was not
observed colocalized with B23 known to be mostly located in the GC of nucleoli. Conversely
fibrillarin-NoLS appeared to strictly colocalize with B23 (Fig. 6e-h) indicating that the
addition of the NoLS to fibrillarin makes it possible to relocalize fibrillarin from the DFC to
the GC of nucleoli, i.e. to confer on fibrillarin the same localization as B23.
It may also be asked whether the addition of NoLS to one subunit of a nucleolar
protein complex could modify the localization of the entire complex. In this case, NoLS might
be used as tool to visualize and to prove protein interactions in the nucleolus by adding NoLS
to one subunit of a nucleolar protein complex and determining whether the other subunits of
the complex are mislocalized. To address this question, we checked the effect of the
mislocalization of fibrillarin in the GC of nucleoli, i.e. when expressed as fibrillarin-NoLS, on
the localization of Nop56, another member of the core proteins of the box C/D snoRNP
complexes. We first verified that both fibrillarin and the fibrillarin partner Nop56 were
colocalized in the DFC of nucleoli when coexpressed in interphasic HeLa cells as fibrillarin-
GFP and DsRed-Nop56 fusions (Fig. 6i-l). The colocalization of both proteins was
maintained when fibrillarin-NoLS and Nop56 were coexpressed in interphasic HeLa cells
(Fig. 6m-p) showing that the mislocalization of fibrillarin in the GC of nucleoli induces the
mislocalization of its partner Nop56. The relocalization of Nop56 into the GC of nucleoli
when it was coexpressed with fibrillarin-NoLS was clearly due to the interaction between
Nop56 and fibrillarin. Indeed no relocalization was observed for Nopp140, a protein that is
not a member of the core proteins of the box C/D snoRNP complexes. As well established,
fibrillarin and Nopp140 were colocalized in the DFC of nucleoli in interphasic HeLa cells
(Fig. 6q-t), but this colocalization was no longer maintained when fibrillarin delocalized into
the GC of nucleoli (Fig. 6u-x). In addition, the fact that the localization of Nopp140 was not
modified in cells expressing fibrillarin-NoLS also indicated that the nucleolar morphology
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was maintained. The expression of fibrillarin-NoLS did not induce disappearance of DFC and
consequently a general delocalization of proteins of the DFC.
The novel NoLS may be used as a new tool to visualize protein interactions in
the cell nucleus
When fused to the fibrillarin, NoLS is able to delocalize fibrillarin from the DFC to the GC of
nucleoli by conferring on fibrillarin high affinity for B23. Moreover, the addition of NoLS to
one subunit of a protein complex could modify the nucleolar localization of the complex.
Consequently, it may be asked whether addition of NoLS to a nuclear protein could modify
the localization of the protein and target it to the nucleolus and whether the addition of the
NoLS to one subunit of a nuclear protein complex could target the entire complex to the
nucleolus. Thus, the NoLS might be used as tool to visualize and to prove protein interactions
in the nucleus.
To answer these questions, the transcription factor NF-E2 composed of two subunits,
MafG and p45 NF-E2, was used as model of a heterodimeric nuclear protein. These two
protein subunits were produced as GFP-P45 and DsRed-MafG fusions and NoLS was added
to the amino-terminus of MafG to generate the DsRed-NoLS-MafG fusion. We first verified
that the GFP-P45 and DsRed-MafG fusions exhibited the expected localization when
expressed in HeLa cells. Indeed, as previously reported (Tramier et al., 2002), both proteins
are localized in the nucleus and are largely excluded from nucleoli as observed by comparing
their position to that of B23 (Fig. 7a-d,e-h). More interestingly, the DsRed-NoLS-MafG
fusion localized in nucleoli and the coexpression of both DsRed-NoLS-MafG and GFP-B23
showed a strict colocalization of both proteins (Fig. 7i-l). Therefore, NoLS made it possible to
modify the localization of MafG and to target it to nucleoli. The capability of NoLS to
relocalize a nuclear protein to the nucleoli and more precisely to the GC of the nucleoli where
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B23 is located, was also verified for CDK9 (our unpublished data).
Concerning the localization of the MafG partner P45, coexpression of both DsRed-
NoLS-MafG and GFP-P45 in HeLa cells showed that the relocalization of MafG in nucleoli
led to the relocalization of most P45 to the same sites (Fig. 7m-p) and thus proved the
interaction of these two proteins when they are coexpressed in HeLa cells. Moreover, the
relocalization of P45 to nucleoli when coexpressed with NoLS-MafG was clearly due to the
interaction between P45 and MafG. Indeed, the expression of DsRed-NoLS in HeLa cells
expressing GFP-P45 did not modify the localization of GFP-P45 (Fig. 7q-t). In addition,
coexpression of GFP-Sirtuin 1, a nuclear protein that possesses no affinity for MafG, with
DsRed-NoLS-MafG did not change the localization of the former protein (Fig. 7u-x). In
conclusion, we propose that adding the NoLS to one subunit of a nuclear protein complex
makes it possible to target the entire complex to the nucleolus. Consequently, such an
approach might be used to demonstrate protein interactions in a cellular context.
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Discussion
A novel NoLS targets GFP to the nucleolus and interacts with B23
In this study, we generated a protein sequence which confers to GFP a specific nucleolar
localization. This “synthetic“ NoLS possesses no significant homology with the NoLSs
previously described except for the presence of a stretch of basic residues as already reported
for viral nucleolus-localizing proteins such as HIV-1 Rev (Kubota et al., 1989), HIV-1 Tat
(Dang and Lee, 1989) and HTLV-1 Rex (Siomi et al., 1988) and for cellular proteins such as
the nucleolar protein p120 (Valdez et al., 1994), Survivin-deltaEx3 (Song and Wu, 2005) and
HSP70 (Dang and Lee, 1989). As demonstrated by the localization of deletion mutants of this
novel NoLS, the stretch of basic residues plays a key role in nucleolar localization.
Interestingly, as observed here, the capability of numerous proteins to adopt a nucleolar
localization is correlated with their interaction with B23 (Adachi et al., 1993; Fankhauser et
al., 1991; Korgaonkar et al., 2005; Li, 1997; Valdez et al., 1994). Because of the ability of
numerous nucleolar proteins to interact with B23 and because this major nucleolar protein
shuttles constantly between nucleus and cytoplasm (Borer et al., 1989), it was often suggested
that B23 might be a transporter for nucleolar proteins possessing a NoLS (Fankhauser et al.,
1991; Li, 1997; Valdez et al., 1994). Even if this tempting hypothesis has never been
demonstrated, recent results obtained on stable U2OS-derived cell lines with reduced B23
expression levels showed that the nucleolar localization of ARF is linked to B23 (Korgaonkar
et al., 2005). Indeed, the reduced expression of B23 induced a partial delocalization of ARF
from nucleoli to nucleoplasm. The authors therefore concluded that B23 targets ARF to
nucleoli in a dose-dependent manner. Nevertheless, this result does not make it possible to
discriminate between a role of B23 in the transport of ARF from nucleoplasm to nucleoli
and/or a role of B23 in the retention of ARF in nucleoli.
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However, contrary to what had been suggested by several authors (Fankhauser et al.,
1991; Li, 1997; Valdez et al., 1994), a role of B23 in the transport of proteins to nucleoli does
not seem mandatory. In fact, the recent analysis of the intranuclear dynamics of proteins in
living cells has shown that nuclear proteins can diffuse within the nucleoplasm (Phair and
Misteli, 2000; Sprague and McNally, 2005). Concerning the nucleolus, it was demonstrated
that nucleolar proteins rapidly associate with and dissociate from nucleolar components in a
continuous exchange with the nucleoplasm (Chen and Huang, 2001; Dundr et al., 2004; Phair
and Misteli, 2000; Snaar et al., 2000). The authors suggest the existence of compartment-
specific retention mechanisms for proteins in nuclear bodies implying that the residence time
of a particular molecule in a given nuclear body depends on its specific interactions (Misteli,
2001). Consequently, protein interactions should govern the nuclear distribution of proteins
and a NoLS might actually be a nucleolar molecule-interacting sequence.
A novel NoLS or a new B23-interacting sequence
The NoLS described here interacts with the central region of B23, i.e. the region including the
two acidic stretches (amino acids 120 to 132 and 161 to 188) as already reported for HTLV-1
Rex (Adachi et al., 1993). B23-NoLS interaction is direct and specific as demonstrated by the
fact that the other nucleolar proteins tested showed no affinity for this novel NoLS. However,
it seems unlikely that B23-NoLS interaction is only electrostatic occurring between the acidic
stretches of B23 and the cluster of basic residues in NoLS. Indeed the other major nucleolar
protein, nucleolin, that possesses four stretches of acidic residues in its N-terminal region
does not interact with NoLS. Whatever type of interaction exists between B23 and NoLS, the
affinity of NoLS for B23 in vitro was stronger than that of the HIV-1 Rev protein for B23.
Therefore, NoLS possesses a strong affinity for B23 in vitro and also in vivo as observed by
the colocalization of the GFP-NoLS fusion and B23 in the GC of nucleoli during interphase,
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and by the fact that NoLS confers to GFP the behavior of B23 during mitosis. In addition,
GFP-NoLS fusion and B23 remain colocalized after actinomycin D or roscovitine treatment.
Furthermore, a selective delocalization of B23 from nucleoli to nucleoplasm induces a
concomitent delocalization of the GFP-NoLS fusion from nucleoli to nucleoplasm because of
B23-NoLS interaction. The behavior of GFP-NoLS during mitosis, i.e. mainly located at the
periphery of chromosomes and recruited in PNBs in telophase, shows that rather than a
sequence that targets the GFP to nucleoli, NoLS appears to be a new B23-interacting
sequence, i.e. a sequence interacting with the major nucleolar protein. It is interesting to note
that B23-NoLS interaction occurs throughout the cell cycle and therefore does not seem to be
influenced by the post-translational modifications of B23. The observation that NoLS is a
B23-interacting sequence in vivo is reinforced by the capacity of NoLS to relocalize
fibrillarin from the DFC to the GC of nucleoli where B23 is localized. By providing fibrillarin
with an additional affinity for B23, the localization of fibrillarin within the nucleolus is
modified.
The new B23-interacting sequence may be used as a new tool to visualize
protein interactions in a cellular context
The proteomic approaches currently developed show us how necessary it is to understand the
relationship between proteins, and in particular between nuclear proteins. Generally, protein
interactions are studied by in vitro experiments. This implies that it is not possible to analyze
interactions based on cellular activities. To date, the most widely used approaches making it
possible to analyze protein interactions in a cellular context are FRET (Selvin, 2000; Wouters
et al., 2001) and bimolecular fluorescence complementation (BiFC) (Hu et al., 2002).
However, with both these methods only direct interactions are accessible.
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Because conferring to a protein an additional strong affinity for B23 makes it possible
to sequester and/or relocalize this protein to or within the nucleolus as verified for GFP,
fibrillarin, MafG (this study) and CDK9 (our unpublished data), we hypothesized that such a
approach might be used to relocalize a protein complex to or within the nucleolus. This
hypothesis was proved correct by analyzing on one hand, two members of the core proteins of
the box C/D snoRNP complexes, namely fibrillarin and Nop56, and on the other hand, the
MafG-P45 complex. This latter complex was chosen because a previous study carried out by
FRET demonstrated MafG-P45 interaction when both proteins are expressed in HeLa cells
(Tramier et al., 2002). Here, we show that the delocalization of fibrillarin from the DFC to the
GC of nucleoli by addition of NoLS results in the co-delocalization of Nop56 from the DFC
to the GC of nucleoli. Similarly the delocalization of MafG from nucleoplasm to nucleoli by
addition of NoLS results in the co-delocalization of P45 to the nucleoli. This co-delocalization
is only observed for interacting proteins and does not occur for the fibrillarin and Nopp140
pair as expected since Nopp140 is not an integral component of the box C/D snoRNP
complexes (Yang et al., 2000); likewise it does not occur for proteins without affinity for each
other such as MafG and Sirtuin 1. Therefore, the co-delocalization of two proteins
demonstrates a strong interaction between these two proteins in a cellular context.
Consequently, this approach based on the targeting of a complex to the GC of nucleoli might
be used to determine whether a given protein interaction occurring in vitro also occurs in vivo
and/or to identify the partner(s) of a specific protein in a cellular context. It is noteworthy that
this new and simple approach for in vivo binding studies is most probably made possible by
the fact that 1) NoLS possesses a strong affinity for B23, i.e. the major nucleolar protein, and
2) B23-NoLS interaction does not seem to be influenced by the post-translational
modifications of B23. Fusing NoLS to a nuclear protein results in the delocalization of this
protein into the GC of nucleoli, a phenomenon easily assessed by fluorescence microscopy.
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This new tool aimed at analyzing protein interactions offers the advantage of assessing
direct protein interactions in a cellular context as well as indirect interactions. Indeed,
contrary to FRET and BiFC based on direct interaction between two proteins, this new
approach is based on the targeting to nucleoli of a protein together with its directly or
indirectly associated partners. In addition, when antibodies are available, direct or indirect
interactions between proteins may be tested by expressing the first protein fused to NoLS and
analyzing by immunofluorescence the possible delocalization to nucleoli of its potential
partners. Moreover, by varying experimental conditions, this simple approach should make it
possible to elucidate protein interactions but also to uncover the mechanisms that regulate
such interactions. In conclusion, this new approach should lead to a better integrated vision of
the cell nucleus.
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Materials and Methods
Cell culture, transfection, immunofluorescence
HeLa cells were cultured in MEM with GlutaMAX™ (Invitrogen) containing 10% FCS and
NIH-3T3 cells in DMEM (Invitrogen) containing 10% FCS and 2 mM L-glutamine
(Invitrogen) in a 5% CO2 incubator at 37°C. Cells were transfected with purified plasmids
using effectene (Qiagen) according to the manufacture's instructions. For synchronization in
mitosis, HeLa cells were accumulated in prometaphase by nocodazole treatment (0.04 µg/ml
for 3 hours), selectively harvested by mechanical shock, washed, and resuspended in
nocodazole-free medium for 30 or 60 minutes. The drugs used were leptomycin B
(Calbiochem) at 20 nM for 4 hours, roscovitine (Calbiochem) at 75 µM for 2 hours and
actinomycin D (Sigma) at 0.1 µg/ml for 2 hours. For immunofluorescence, cells were plated
on a coverslip in 6-well plates (Techno Plastic Products AG) and transfected 24 hours later. At
16-24 hours post transfection, the cells were fixed in 2% paraformaldehyde for 20 minutes at
room temperature, permeabilized with 0.5% Triton X-100 for 5 minutes and prepared for
fluorescence microscopy as previously described (Sirri et al., 2002). Alternatively, the cells
were fixed with 100% methanol for 10 minutes at -20°C, dried and rinsed several times with
PBS before being incubated with antibodies. The antibodies used were goat polyclonal anti-
B23 (Santa Cruz Biotechnology), mouse monoclonal anti-B23 (Sigma), a previously
characterized human autoimmune serum with specificity against fibrillarin (O61; Sirri et al.,
2002) and Texas Red-conjugated secondary antibodies specific for goat, mouse and human
IgGs (Jackson ImmunoResearch Laboratories). Samples were incubated with 4,6-diamidino-
2-phenylindole (DAPI) to visualize DNA and mounted with the antifading solution AF1
(Citifluor). Fluorescence microscopy was performed using a CCD camera Leitz DMRB and
images assembled using Adobe Photoshop.
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Plasmid constructs
Entire or partial DNA sequences encoding the NoLS were amplified by PCR with specific
primers inserting the restriction sites EcoRI and BamHI respectively in the 5’ and 3’ ends of
the PCR products. Partial DNA sequences of NoLS were cloned into the EcoRI/BamHI sites
of pEGFP-C2 (Clontech) and the entire NoLS sequence into the EcoRI/BamHI sites of both
pEGFP-C2 and pDsRed-m-C1 (Clontech). The same strategy was used to clone NoLS and
B23 into the BamHI/EcoRI sites of the pGEX4T1 (Amersham) to generate the GST-NoLS
and GST-B23 constructs. GST-Rev was obtained by subcloning the DNA sequence encoding
HIV-1 Rev from pAS1B-Rev (kindly provided by E. Le Rouzic, Institut Cochin, Paris,
France) into the EcoRI/XhoI sites of pGEX4T1. Full-length and B23 mutants were prepared
by PCR-amplification from full-length human cDNA (clone IMAGE 5575414) and
subcloning into the EcoRI/BamHI sites of pEGFP-C1 (Clontech) for full-length B23 and
mutant B23/121-186, or of pDsRed-m-C1 for full-length B23 and mutants B23/1-119, B23/1-
132, B23/1-160, B23/1-186 and B23/187-294. GFP-B23-NES was kindly provided by B.
Falini and N. Bolli (University of Perugia, Perugia, Italy) and corresponds to pEGFP-C1-
NPMmA (Falini et al., 2005). Fibrillarin-GFP and fibrillarin-RFP were obtained by PCR-
amplification from human cDNA and subcloning into the EcoRI/BamHI sites of pEGFP-N1
(Clontech) and pmRFP-N1 kindly provided by R.Y. Tsien (University of California, San
Diego, USA). Fibrillarin cDNA and the DNA sequence of NoLS were fused by the “gene
soeing” strategy and the PCR product subcloned into the EcoRI/BamHI sites of pEGFP-N1
and pmRFP-N1 to obtain respectively fibrillarin-NoLS-GFP and fibrillarin-NoLS-RFP.
DsRed-Nop56 was prepared by PCR-amplification from full-length mouse cDNA (clone
IMAGE 5006404) and subcloning into the SalI/BamHI sites of pDsRed-m-C1. GFP-Nopp140
was obtained by PCR-amplification from rat cDNA kindly provided by T. Meier (Albert
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Einstein College of Medicine of Yeshiva University, New York, USA) and subcloning into
the EcoRI/BamHI sites of pEGFP-C2. P45 and MafG were PCR-amplified from mouse
cDNAs kindly provided by V. Mignotte (Institut Cochin, Paris, France), and cloned into the
EcoRI/BamHI sites of pEGFP-C1 and pDsRed-m-C1, respectively. DsRed-NoLS-MafG was
constructed by inserting the entire NoLS DNA sequence into the XhoI/EcoRI sites of
pDsRed-m-C1-MafG. GFP-Sirtuin 1 was obtained by PCR-amplification of the DNA
sequence encoding human Sirtuin 1 from pBST-SIRT1 kindly provided by F. Ishikawa
(Kyoto University, Kyoto, Japon) and subcloning into the SalI/BamHI sites of pEGFP-C1.
The sequences of the oligonucleotides used for PCR-amplifications are available upon
request.
Pull down experiments
For in vitro pull down assays, the GST, GST-NoLS and GST-Rev proteins were
overexpressed in E. coli (BL21 DE3) and then induced 3 hours with 0.1 mM IPTG at 37°C.
Lysates were obtained by enzymatic reaction with lysozyme (100 µg/ml) and DNase I (20
ng/µl) and clarified by ultracentrifugation at 65,000 g for 30 minutes. The clarified lysates
were incubated with glutathione-sepharose beads (Amersham) for 2 hours at 4°C. GST fusion
proteins bound to glutathione-sepharose beads were washed four times with wash buffer 1 (50
mM Tris-HCl pH 8, 1 M NaCl, 10% glycerol and complete) and once with binding buffer (50
mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.2% NP40, 10% glycerol and complete).
Complete corresponds to a cocktail of protease inhibitors (Roche). Proteins of HeLa cells
transfected or not were extracted using lysis buffer (50 mM Tris-HCl pH 7.4, 500 mM NaCl,
1 mM EDTA, 1% NP40, 10% glycerol and complete). After centrifugation at 16,000 g for 15
minutes, the supernatants were adjusted to the binding buffer conditions and these whole cell
extracts were incubated with fusion proteins bound to glutathione-sepharose beads. After
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gentle shaking overnight at 4°C, the beads were centrifuged at 500 g for 2 minutes and
washed four times in wash buffer 2 (50 mM Tris-HCl pH 7.4, 250 mM NaCl, 1 mM EDTA,
0.2% NP40, 10% glycerol and complete). In experiments comparing NoLS and Rev affinities,
the incubations were performed for times varying from 1.5 to 20 hours. Purified B23 was
produced by digestion of GST-B23 overexpressed in E. coli with thrombin (1 unit for 30 µl of
beads) and purification on glutathione-sepharose beads as described above. For pull down
assays performed with purified B23, the incubation time was 2 hours. In all cases, proteins
corresponding to extracts recovered before and after pull down assays and proteins bound to
beads were resuspended in SDS loading buffer, resolved by SDS-PAGE and analyzed by
coomassie blue staining and immunoblotting.
Immunoblot analyses
Proteins resolved by 10% SDS-PAGE were transferred to nitrocellulose membranes and
incubated with the following antibodies: rabbit polyclonal anti-B23 (kindly provided by M. O.
J. Olson, University of Mississippi Medical Center, Jackson, USA), rabbit polyclonal anti-
GFP (Roche), mouse monoclonal anti-nucleolin (Santa Cruz Biotechnology), and human
autoimmune sera with specificities against Nop52 (C13; Savino et al., 1999) and Nopp140
(A10; characterized in the present study). The membranes were then incubated with
horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch
Laboratories) and the immunoreactivity was detected by chemiluminescence (Amersham) and
quantified using MetaMorph® software (Universal Imaging Corp.) by measuring the average
intensity of the bands.
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Figure legends
Fig. 1. A “synthetic” NoLS targets GFP to nucleoli. (A) Schematic representation of the
generation of NoLS. The upper diagram corresponds to the DNA sequence encoding human
Sirtuin 1, the middle one to the PCR product after misreading of the DNA polymerase and the
bottom one to the resulting mutant protein. A partial nucleotide sequence of Sirtuin 1 is
indicated in the upper diagram, and the corresponding misread sequence is indicated in the
middle diagram. The resulting mutant protein corresponds to the first 87 amino acids of
Sirtuin 1 (∆ Sirtuin 1) followed by a “synthetic” sequence of 93 amino acids (NoLS). The
numbers are nucleotide or amino acid positions. (B) NoLS with the stretch of basic residues in
red. (C) Constructs of NoLS containing the entire or partial basic stretch in red. (D)
Fluorescence microscope observations of the NoLS constructs fused to GFP and expressed in
HeLa cells. Only the constructs possessing the stretch of basic residues were predominantly
(NoLS/31-63, i,j and NoLS/1-50, e,f), if not exclusively (NoLS, a,b and NoLS/33-93, c,d)
localized in nucleoli whereas the other constructs were not (NoLS/51-93, k,l) or only slightly
(NoLS/1-32, g,h) enriched in nucleoli. Arrowheads in panel b indicate nucleoli visible by
phase-contrast image. Bar, 10 µm.
Fig. 2. NoLS interacts directly with B23; this interaction involves the acidic stretches of B23.
(A) GST and GST-NoLS pull down assays carried out using whole HeLa cell extracts. 1% of
the extract used for each pull down assay (Input), 1% of the supernatant (S) and 1.5% of the
proteins eluted from the bead pellet (P) after the indicated pull down assay were
electrophoresed and immunoblotted to detect B23, Nopp140, Nucleolin and Nop52. B23
interacts specifically with GST-NoLS but not with GST. On the contrary, Nopp140,
Nucleolin and Nop52 do not interact with GST-NoLS. (B) GST and GST-NoLS pull down
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assays carried out using a purified recombinant B23. 2% of the supernatant (S) and 3% of the
proteins eluted from the bead pellet (P) after the indicated pull down assay were
electrophoresed and immunoblotted to detect B23. B23-NoLS interaction is direct. (C) Pull
down assays performed on whole extracts prepared from HeLa cells transiently tranfected
with B23 wild-type (B23 wt) and B23 mutants fused to the C-terminus of GFP or DsRed as
indicated. The mutants B23/121-186, B23/1-119, B23/1-132, B23/1-160, B23/1-186 and
B23/187-294 correspond to the B23 mutants possessing the B23 residues 121-186, 1-119, 1-
132, 1-160, 1-186 and 187-294, respectively. Black boxes on the schematic representations
correspond to the stretches of acidic amino acids present in the B23 sequence. 1.5% of the
extracts used for each pull down assay (Input) and 3% of the proteins eluted after the GST-
NoLS pull down assay (GST-NoLS) were electrophoresed and immunoblotted using anti-B23
or anti-GFP antibodies. Only B23 mutants possessing at least one stretch of acidic amino
acids interact with GST-NoLS. Asterisks indicate the endogenous B23 revealed only with the
anti-B23 antibodies but not with the anti-GFP antibodies. Arrowheads point the
overexpressed tagged-B23 or -mutant B23.
Fig. 3. NoLS possesses a stronger affinity for B23 than does HIV-1 Rev. Pull down
experiments were performed using GST, GST-NoLS and GST-Rev on the same whole HeLa
cell extract for increasing incubation times (1.5, 3 and 20 hours) and the binding of B23 was
analyzed. (A) 1.5% of the proteins eluted after each pull down assay was electrophoresed and
analyzed by coomassie blue staining. No significant loss of GST, GST-NoLS or GST-Rev
occurred during the pull down assays. (B) 1.5% of the extract used for each pull down assay
(Input) and 1.5% of the proteins eluted after the indicated pull down assay were
electrophoresed and immunoblotted using anti-B23 antibodies. The signals corresponding to
B23 were quantified and are expressed as a percentage of B23 present in the input. Contrary
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to GST, both GST-NoLS and GST-Rev bound B23 but B23-NoLS interaction occurred more
rapidly and more efficiently than B23-Rev interaction.
Fig. 4. Localization of GFP-NoLS in HeLa cells during the cell cycle. (A) HeLa cells were
transfected with GFP-NoLS fusion and analyzed by fibrillarin or B23 immunolabeling (a,e),
GFP-NoLS observation (b,f) and phase-contrast (d,h). The nucleolar localization of NoLS in
interphasic cells was demonstrated using fibrillarin a marker of the DFC, and B23
preferentially localized to the GC of nucleoli. GFP-NoLS did not colocalize with fibrillarin as
observed by comparing the enlargements (a-c, insets), whereas it colocalized with B23 as
observed by comparing the enlargements (e-g, insets). (B) HeLa cells cotransfected with
GFP-NoLS and DsRed-B23 were synchronized in mitosis. GFP-NoLS observations (a,e,i),
DsRed-B23 observations (b,f,j) and superimpositions of both labelings in the same mitotic
cells (c,g,k). The mitotic stage was determined by DAPI staining (d,h,l). GFP-NoLS
colocalized with DsRed-B23 at the chromosome periphery in metaphase (a-d) and in
numerous foci, the PNBs, in telophase (e-h) and early G1 (i-l). In early G1, GFP-NoLS and
DsRed-B23 colocalized in the reformed nucleoli. These nucleoli are indicated by arrowheads
(i-k). Bars, 10 µm.
Fig. 5. NoLS still colocalizes with B23 after actinomycin D or roscovitine treatment and is
delocalized from nucleoli to nucleoplasm when the endogenous B23 is selectively delocalized
from nucleoli to nucleoplasm. (A) HeLa cells cotransfected with GFP-NoLS and mDsRed-
B23 or with GFP-NoLS and fibrillarin-RFP were treated with actinomycin D (a-h), or
roscovitine (i-p). After actinomycin D treatment, NoLS colocalized with B23 in the
segregated nucleolus (a-d) but was excluded from the fibrillarin-containing caps (e-h). After
roscovitine treatment, NoLS colocalized with B23 in large nuclear bodies (i-l) but not with
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fibrillarin (m-p). (B) NIH-3T3 cells were transfected with GFP-B23-NES and analyzed by
B23 immunolabeling (a-c) or cotransfected with GFP-B23-NES and DsRed-NoLS (d-f). After
leptomycin B treatment, GFP-B23-NES was located in the nucleus and mostly excluded from
nucleoli (a, arrowheads). Anti-B23 antibodies, revealing both endogenous and mutated B23,
labeled the nucleoplasm and only slightly the nucleoli of GFP-B23-NES-expressing cells
contrary to what was observed in cells not expressing GFP-B23-NES in which B23 labeling
was mostly restricted to nucleoli (b). Thus, the endogenous B23 was mostly excluded from
nucleoli in NIH-3T3 cells expressing GFP-B23-NES. In cells expressing GFP-B23-NES (d),
DsRed-NoLS (e) was also mostly delocalized from nucleoli to nucleoplasm. Arrowheads
point to nucleoli. Bars, 10 µm.
Fig. 6. Fusion of NoLS to fibrillarin makes it possible to delocalize fibrillarin from the DFC
to the GC of nucleoli; this mislocalization of fibrillarin in the GC of nucleoli induces the
mislocalization of the fibrillarin partner Nop56 in the GC but does not affect the localization
of Nopp140. HeLa cells were cotransfected with fibrillarin-GFP and DsRed-B23 (a-d), with
fibrillarin-NoLS-GFP and DsRed-B23 (e-h), with fibrillarin-GFP and DsRed-Nop56 (i-l),
with fibrillarin-NoLS-GFP and DsRed-Nop56 (m-p), with fibrillarin-RFP and GFP-Nopp140
(q-t), or with fibrillarin-NoLS-RFP and GFP-Nopp140 (u-x). Fibrillarin (a) localized in the
DFC of nucleoli contrary to B23 (b) that localized preferentially in the GC as evidenced by
the superimposition of both labelings (c) and by the comparison with the phase contrast image
(d). When fused to NoLS, fibrillarin (e) was delocalized from the DFC to the GC of nucleoli
and therefore colocalized with B23 (f) as evidenced by the superimposition of both labelings
(g). Fibrillarin (i) colocalized with Nop56 (j) in the DFC of nucleoli as evidenced by the
superimposition of both labelings (k). The delocalization of fibrillarin in the GC of nucleoli
by the fusion of the NoLS (m) similarly modified the nucleolar localization of Nop56 (n), and
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therefore both proteins still colocalized as demonstrated by the superimposition of both
labelings (o). Fibrillarin (q) and Nopp140 (r) colocalized in the DFC of nucleoli as evidenced
by the superimposition of both labelings (s). Contrary to Nop56, the delocalization of
fibrillarin fused to NoLS (u) did not modify the nucleolar localization of Nopp140 (v) as
shown by the superimposition of both labelings (w). Bar, 10 µm.
Fig. 7. The fusion of NoLS to MafG makes it possible to delocalize the nuclear complex
MafG-P45 to nucleoli. HeLa cells were cotransfected with GFP-P45 and DsRed-B23 (a-d),
with DsRed-MafG and GFP-B23 (e-h), with DsRed-NoLS-MafG and GFP-B23 (i-l), with
DsRed-NoLS-MafG and GFP-P45 (m-p), with DsRed-NoLS and GFP-P45 (q-t) or with
DsRed-NoLS-MafG and GFP-Sirtuin 1 (u-x). P45 (a) and MafG (e) were localized in the
nucleus and excluded from the nucleoli as observed by comparing with B23 localization
(compare a,b and e,f) and by the superimpositions of labelings (c,g). When fused to NoLS,
MafG (i) colocalized with B23 (j) in nucleoli as evidenced by the superimposition of both
labelings (k). Targeting of MafG to nucleoli by addition of the NoLS induced a clear
relocalization of P45 to the nucleoli (compare m, n, o and the phase contrast image p).
Coexpression of DsRed-NoLS and GFP-P45 (q-t) showed that the expression of NoLS did not
modify the nuclear localization of P45. Contrary to P45, targeting of MafG to nucleoli by the
addition of NoLS (u) did not modify the nuclear localization of Sirtuin 1 (v). Bar, 10 µm.
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